Thursday, February 25, 2010

OncoGenex Loses CFO

Bothell-based OncoGenex Pharmaceuticals, a firm developing and commercializing cancer therapies, said late Wednesday that its CFO, Steve Anderson, is leaving the firm. The company said that the company has launched a search for a new CFO. OngoGenex said the move came after both the company and Anderson agreed he will leave the firm. The company said it hopes to find a CFO candidate suited for the "next stage of company growth", and who has deep ties into the biopharma investment community. OncoGenex said the move is a "recognition of the company moving to a new stage in its development."